Evidence map›Paper›PMID 32036586›Full record

ArticleClinical rheumatology2020

Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort.

Lei Zhang, Tian-Ge Wu, Yu-Jie He, Jin-Yan Guo, Li-Shuai Han, Jia-Meng Lu, Sheng-Yun Liu, Tian-Fang Li

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. [Relapsing polychondritis].Zeitschrift fur Rheumatologie · 2023
    Article
  7. Imaging features and clinical value ofArthritis research & therapy · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lei ZhangRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Tian-Ge WuRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yu-Jie HeRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jin-Yan GuoRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Li-Shuai HanRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jia-Meng LuRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Sheng-Yun LiuRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. fccliusy2@zzu.edu.cn.
Tian-Fang LiRheumatology Department, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. tfli@zzu.edu.cn.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe diagnosis of relapsing polychondritis (RP) is often mistaken or delayed. In this retrospective cohort, we aimed to unveil the causes responsible for such phenomenon, to determine the associated factors, and to compare diagnosis in clinical settings with the current diagnostic criteria.

methodEighty-seven RP patients followed-up by rheumatologists from January 1, 2008, to October 31, 2018, were retrospectively analyzed.

resultsA total of 50 male and 37 female patients were included with a mean age of 45.9 ± 14.5 years. Ninety-three percent were initially admitted by non-rheumatologic specialists .Twenty-eight percent were correctly diagnosed, while 72% were misdiagnosed at the first visits, all by non-rheumatologic specialists. Patients admitted by non-rheumatologic specialists had increased odds of misdiagnosis (odds ratio [OR] = 1.3, 95% confidence interval [95% CI] 1.1-1.7, P = 0.000). Fifty-seven (65.5%) patients did not meet with Michet or Damiani criteria, with 16 (18.4%) patients diagnosed as partial RP and 41( 47.1%) patients diagnosed as limited RP.

conclusionsIncorrect and delayed diagnosis of RP is common in our cohort, and insufficient awareness of the disease in non-rheumatologic specialists at least partially contributes to this. It is imperative to revise the current criteria for early diagnosis.Key Points• Diagnosing relapsing polychondritis (RP) in early stage remains challenging after all these years, especially among non-rheumatologic specialists, indicating the importance of teaching non-rheumatologic specialists to improve their understanding of this rare disease.• Many RP patients did not fully meet with the current criteria, suggesting that revision of the current criteria is imperative for early diagnosis of this rare disease.

Indexed as

AdultChinaDiagnostic ErrorsFemaleHumansMaleMiddle AgedPolychondritis, RelapsingRetrospective StudiesSurvival RateClinical featuresCriteriaDelayMisdiagnosisRelapsing polychondritis

Identifiers

PMID32036586
OpenAlexW3004762640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.